MET

NYSE

METLIFE INC

Financials, Life & Health Insurance

$97.77

close 7 Aug 2026

+29.84%

52-week change

$62.35B

market cap

$67.33

$100.93

52-week range

Valuation

Market cap$62.35B

P/E (TTM / 5y avg)18.69x15.75x

Forward P/E (FY2026 / FY2027)9.98x8.97x

PEG (TTM / fwd)—0.89

P/S (TTM)0.79x

P/B2.27x

EV/EBITDA (TTM)—

FCF yield (TTM)—

Cash flow & dividend

FCF (TTM)—

FCF per share (TTM)—

FCF margin (TTM)—

Dividend yield (indicated / 5y avg)2.43%2.99%

Annualized dividend$2.37

Payout ratio (EPS / FCF)41.59%—

Growth & quality

Revenue YoY, latest Q+10.46%

Diluted EPS YoY, latest Q+5.83%

Operating margin (TTM)8.27%

Net margin (TTM)4.57%

ROE (latest FY)11.90%

Net debt / EBITDA (TTM)—

Interest coverage (TTM)—

Price

+56.46%+9.40%/yrover 5y

Weekly closes · split-adjusted

close 7 Aug 2026

Fundamentals

Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar

Revenue

5Y CAGR +2.59%10Y CAGR +2.31%

Diluted EPS

5Y CAGR -3.68%10Y CAGR +0.19%

Operating cash flow

5Y CAGR +7.99%10Y CAGR +1.98%

Dividends per share

5Y CAGR +3.86%10Y CAGR +4%

Payout ratio

Operating margin

Return on equity

Shares outstanding

5Y CAGR -6%10Y CAGR -6.12%

Earnings

Street estimates, not SEC filings

Next / Q3 FY26

Date3 Nov 2026amc

EPS estimate$2.56

Revenue estimate$20.24B

Last reported

Date—

EPS——

Revenue——